NSAIDs potentially modulate neuroinflammatory processes in Visual Snow Syndrome by inhibiting cyclooxygenase (COX) enzymes, thereby reducing prostaglandin synthesis and neurogenic inflammation. Their anti-inflammatory and analgesic properties may help mitigate neurological hyperexcitability and sensory processing abnormalities associated with the syndrome, though their efficacy is primarily based on theoretical mechanisms and limited clinical observations.